Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Guardant Health, Inc. GH NASDAQ

NASDAQ Global Select • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
57/100
4/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$134.21
+55.3%

Guardant Health, Inc. (GH) has 12 identified peers for comparison in the Healthcare sector. Peers include A, CDNA, CRL, CSTL, DHR, ILMN and others.

GH has a market capitalization of $11.33B, compared to an average peer market cap of $36.31B. GH is notably smaller than its average peer.

People Also View

TMO
TMO
Thermo Fisher Scientific Inc.
$527.22
+2.53%
 DHR
DHR
Danaher Corporation
$198.61
+1.40%
 A
A
Agilent Technologies, Inc.
$120.40
+2.47%
 NTRA
NTRA
Natera, Inc.
$214.64
+6.31%
 ILMN
ILMN
Illumina, Inc.
$130.32
+2.65%
 CRL
CRL
Charles River Laboratories International, Inc.
$179.31
+0.54%
 TWST
TWST
Twist Bioscience Corporation
$57.41
+13.95%
 CDNA
CDNA
CareDx, Inc
$17.63
+4.75%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message